psalexa
logo

Muscle Relaxant Drugs Market

Global Muscle Relaxant Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Facial Aesthetic Relaxant Drug (Botox, Dysport, and Others), By Skeletal Muscle Relaxant Drug (Baclofen, Methocarbamol, Carisoprodol, Metaxalone, Tizanidine, and Others), and by Neuromuscular Blocking Agent (Non-depolarizing Agents, and Depolarizing Agents)

Published: January 2016
Report Code: LS10563
Available Format:
Pages: 87

Chapter 1. Research Scope & Methodology

1.1 Market Definition

1.2 Objective

1.3 Market Scope

1.3.1 Market breakdown by type

1.3.2 Market breakdown by drugs

1.3.3 Market breakdown by geography

1.4 Research Methodology and Sources    

Chapter 2. Executive Summary

2.1 Key Findings

2.2 Research Summary

Chapter 3. Market Outlook

3.1 Introduction

3.1.1 Applications of muscle relaxants

3.1.1.1 Applications of muscle relaxants in musculoskeletal problems    

3.1.1.2 Uses of muscle relaxants in anesthesia

3.1.1.3 Applications of muscle relaxants in facial aesthetics

3.2 Trends in the Muscle Relaxant Market

3.2.1 Growing online retailing of muscle relaxant drugs

3.2.2 Increasing popularity of muscle relaxant treatments in the cosmetic industry     

3.3 Factors Driving Growth of the Market and its Impact on Market Forecast

3.3.1 Growing geriatric population  

3.3.2 Increasing prevalence of skin diseases and harmful effects of ultra-violet radiation

3.3.3 Increasing usage of neuromuscular blocking agents in surgeries   

3.3.4 Increase in disposable income leading to increase in spends on facial aesthetic therapies

3.3.5 Impact analysis of drivers on market forecast

3.4 Factors Hindering Growth of the Market and its Impact on Market Forecast

3.4.1 High capital expenditure

3.4.2 Stringent regulatory requirements    

3.4.3 Risks associated with muscle relaxants

3.4.4 Impact analysis of restraints on market forecast

Chapter 4. Global Muscle Relaxant Drugs Market Size and Forecast (2011 – 2020)       

4.1 Global Muscle Relaxant Drugs Market, by Type

4.2 Global Muscle Relaxant Drugs Market, by Geography

Chapter 5. Global Muscle Relaxant Drugs Market, by Type

5.1 Facial Aesthetic Relaxants Market

5.1.1 Facial aesthetic muscle relaxants market, by region

5.1.2 Facial aesthetic muscle relaxants market, by drug  

5.2 Skeletal Muscle Relaxants Market       

5.2.1 Skeletal muscle relaxants market, by geography   

5.2.2 Skeletal muscle relaxants market, by drug  

5.3 Neuromuscular Blocking Agents Market

5.3.1 Neuromuscular blocking agents market, by geography

5.3.2 Neuromuscular blocking agents market, by type

Chapter 6. Global Muscle Relaxant Drugs Market, by Geography

6.1 North America Muscle Relaxant Drugs Market

6.1.1 North America muscle relaxant drugs market, by type

6.1.2 North America muscle relaxant drugs market, by country 

6.2 Europe Muscle Relaxant Drugs Market

6.2.1 Europe muscle relaxant drugs market, by type

6.2.2 Europe muscle relaxant drugs market, by country

6.3 Asia Muscle Relaxant Drugs Market     

6.3.1 Asia muscle relaxant drugs market, by type

6.3.2 Asia muscle relaxant drugs market, by country

6.4 Rest of the World Muscle Relaxant Drugs Market      

6.4.1 RoW muscle relaxant drugs market, by type

Chapter 7. Drug Approval Process in the U.S. and EU

7.1 Drug approval process in the U.S.

7.2 Drug approval process in the EU

Chapter 8. Competitive Positioning and Market Share Analysis

8.1 Porter's Five Forces of Competitive Position Analysis

8.1.1 Bargaining power of buyers  

8.1.2 Bargaining power of suppliers

8.1.3 Threat of new entrants

8.1.4 Intensity of rivalry

8.1.5 Threat of substitutes  

8.2 Global Muscle Relaxant Drugs Market Share Analysis

Chapter 9. Company Profiles and Strategic Developments

9.1 Key Company Profiles

9.1.1 F. Hoffmann-La Roche Ltd

9.1.1.1 Business overview

9.1.1.2 Product and service offerings

9.1.2 Johnson & Johnson

9.1.2.1 Business overview

9.1.2.2 Product and service offerings

9.1.3 GlaxoSmithKline plc

9.1.3.1 Business overview

9.1.3.2 Product offerings

9.1.4 Intas Pharmaceuticals Ltd.

9.1.4.1 Business overview

9.1.4.2 Product offerings

9.1.5 Pfizer Inc.

9.1.5.1 Business overview

9.1.5.2 Product offerings

9.1.6 Galderma S.A.

9.1.6.1 Business overview

9.1.6.2 Product offerings

9.1.7 Merck & Co., Inc.

9.1.7.1 Business overview

9.1.7.2 Product offerings

9.2 Strategic Developments in the Muscle Relaxant Drugs Market

Chapter 10. Appendix

10.1 List of Abbreviations    

 

LIST OF TABLES

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 2 GLOBAL MUSCLE RELAXANT DRUGS MARKET SNAPSHOT

TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5 GLOBAL MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2011-2014)

TABLE 6 GLOBAL MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 7 GLOBAL MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2011-2014)

TABLE 8 GLOBAL MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020)

TABLE 9 GLOBAL FACIAL AESTHETIC MUSCLE RELAXANTS MARKET BREAKDOWN BY GEOGRAPHY, $M (2011-2014)

TABLE 10 GLOBAL FACIAL AESTHETIC MUSCLE RELAXANTS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020)

TABLE 11 GLOBAL FACIAL AESTHETIC MUSCLE RELAXANTS MARKET BREAKDOWN BY DRUG, $M (2011-2014)

TABLE 12 GLOBAL FACIAL AESTHETIC MUSCLE RELAXANTS MARKET BREAKDOWN BY DRUG, $M (2015 – 2020)

TABLE 13 GLOBAL SKELETAL MUSCLE RELAXANTS MARKET BREAKDOWN BY GEOGRAPHY, $M (2011-2014)

TABLE 14 GLOBAL SKELETAL MUSCLE RELAXANTS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020)

TABLE 15 GLOBAL SKELETAL MUSCLE RELAXANTS MARKET BREAKDOWN BY DRUG, $M (2011-2014)

TABLE 16 GLOBAL SKELETAL MUSCLE RELAXANTS MARKET BREAKDOWN BY DRUG, $M (2015 – 2020)

TABLE 17 GLOBAL NEUROMUSCULAR BLOCKING AGENTS MARKET BREAKDOWN BY GEOGRAPHY, $M (2011-2014)

TABLE 18 GLOBAL NEUROMUSCULAR BLOCKING AGENTS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020)

TABLE 19 GLOBAL NEUROMUSCULAR BLOCKING AGENTS MARKET BREAKDOWN BY TYPE, $M (2011-2014)

TABLE 20 GLOBAL NEUROMUSCULAR BLOCKING AGENTS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 21 NORTH AMERICA MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2011-2014)

TABLE 22 NORTH AMERICA MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2015–2020)

TABLE 23 NORTH AMERICA MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2011-2014)

TABLE 24 NORTH AMERICA MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2015–2020)

TABLE 25 EUROPE MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2011-2014)

TABLE 26 EUROPE MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2015–2020)

TABLE 27 EUROPE MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2011-2014)

TABLE 28 EUROPE MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2015–2020)

TABLE 29 ASIA MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2011-2014)

TABLE 30 ASIA MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2015–2020)

TABLE 31 ASIA MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2011-2014)

TABLE 32 ASIA MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2015–2020)

TABLE 33 ROW MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2011-2014)

TABLE 34 ROW MUSCLE RELAXANT DRUGS MARKET BREAKDOWN BY TYPE, $M (2015–2020)

TABLE 35 F. HOFFMANN-LA ROCHE LTD – KEY FACTS

TABLE 36 JOHNSON & JOHNSON – KEY FACTS

TABLE 37 GLAXOSMITHKLINE PLC – KEY FACTS

TABLE 38 INTAS PHARMACEUTICALS LTD. – KEY FACTS

TABLE 39 PFIZER INC. – KEY FACTS

TABLE 40 GALDERMA S.A. – KEY FACTS

TABLE 41 MERCK & CO., INC. – KEY FACTS

 

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE FOR GLOBAL MUSCLE RELAXANT DRUGS MARKET

FIG 2 RESEARCH METHODOLOGY FOR GLOBAL MUSCLE RELAXANT DRUGS MARKET

FIG 3 APPLICATIONS OF MUSCLE RELAXANTS

FIG 4 CATEGORIES OF SKELETAL MUSCLE RELAXANTS AND THEIR MAJOR DRUGS

FIG 5 TYPES OF NEUROMUSCULAR BLOCKING AGENTS

FIG 6 TYPES OF DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS, BY TIME OF ACTION

FIG 7 USAGE OF MUSCLE RELAXANTS IN FACIAL AESTHETICS

FIG 8 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION IN MAJOR COUNTRIES

FIG 9 BASIC DRUG DEVELOPMENT PROCEDURE

FIG 10 GLOBAL MUSCLE RELAXANT DRUGS MARKET SIZE, $M (2011 – 2020)

FIG 11 GLOBAL MUSCLE RELAXANT DRUGS MARKET SIZE BY TYPE, $M (2011 – 2020)

FIG 12 GLOBAL MUSCLE RELAXANT DRUGS MARKET SIZE BY GEOGRAPHY, $M (2011 – 2020)

FIG 13 GLOBAL FACIAL AESTHETIC RELAXANTS MARKET SIZE, $M (2011 – 2020)

FIG 14 GLOBAL FACIAL AESTHETIC MUSCLE RELAXANT DRUGS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 15 GLOBAL FACIAL AESTHETIC MUSCLE RELAXANTS MARKET SIZE BY GEOGRAPHY, $M (2011 – 2020)

FIG 16 GLOBAL FACIAL AESTHETIC MUSCLE RELAXANTS MARKET SIZE BY DRUG, $M (2011 – 2020)

FIG 17 GLOBAL SKELETAL MUSCLE RELAXANTS MARKET SIZE, $M (2011 – 2020)

FIG 18 GLOBAL SKELETAL MUSCLE RELAXANTS MARKET SHARE, BY GEOGRAPHY (2014 AND 2020)

FIG 19 GLOBAL SKELETAL MUSCLE RELAXANTS MARKET SIZE BY GEOGRAPHY, $M (2011 – 2020)

FIG 20 GLOBAL SKELETAL MUSCLE RELAXANTS MARKET SIZE BY DRUG, $M (2011 – 2020)

FIG 21 GLOBAL NEUROMUSCULAR BLOCKING AGENTS MARKET SIZE, $M (2011 – 2020)

FIG 22 GLOBAL NEUROMUSCULAR BLOCKING AGENTS MARKET SHARE, BY GEOGRAPHY (2014 AND 2020)

FIG 23 GLOBAL NEUROMUSCULAR BLOCKING AGENTS MARKET SIZE BY GEOGRAPHY, $M (2011 – 2020)

FIG 24 GLOBAL NEUROMUSCULAR BLOCKING AGENTS MARKET SIZE BY TYPE, $M (2011 – 2020)

FIG 25 GLOBAL MUSCLE RELAXANT DRUGS MARKET SIZE, BY COUNTRY

FIG 26 NORTH AMERICA MUSCLE RELAXANT DRUGS MARKET SIZE, $M (2011 – 2020)

FIG 27 NORTH AMERICA MUSCLE RELAXANT DRUGS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 28 NORTH AMERICA MUSCLE RELAXANT DRUGS MARKET SHARE, BY COUNTRY (2014)

FIG 29 EUROPE MUSCLE RELAXANT DRUGS MARKET SIZE, $M (2011–2020)

FIG 30 EUROPE MUSCLE RELAXANT DRUGS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 31 EUROPE MUSCLE RELAXANT DRUGS MARKET SHARE, BY COUNTRY (2014)

FIG 32 ASIA MUSCLE RELAXANT DRUGS MARKET SIZE, $M (2011–2020)

FIG 33 ASIA MUSCLE RELAXANT DRUGS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 34 ASIA MUSCLE RELAXANT DRUGS MARKET SHARE, BY COUNTRY (2014)

FIG 35 ROW MUSCLE RELAXANT DRUGS MARKET SIZE, $M (2011–2020)

FIG 36 ROW MUSCLE RELAXANT DRUGS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 37 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS

FIG 38 MARKET SHARE OF KEY PLAYERS IN THE GLOBAL MUSCLE RELAXANT DRUGS MARKET (2014)

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 4500
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 5500
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 8500

Pre-Purchase Enquiry